March 19 (Reuters) - UnitedHealth Group's UNH.N pharmacy benefit manager, Optum Rx, will eliminate up to 25% of the annual reauthorization requirements for certain drugs, lowering the need of prior authorizations required before patients can access the drugs, the company said on Wednesday.
(Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)
((Sriparna.Roy@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.